1996-06-01
A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone
Publication
Publication
Annals of Hematology , Volume 72 - Issue 6 p. 371- 373
A 44-year-old man suffering from cytogenetically and molecularly proven Philadelphia translocation-positive chronic myelogenous leukemia in chronic phase was treated with busulfan for 18 months and studied during a follow-up period of 13 years. Hematologically and cytogenetically, he attained a continuing complete remission, although at one point (9.5 years) at least, after attaining complete remission molecular analysis indicated the presence of minimal residual disease.
| Additional Metadata | |
|---|---|
| , , , , | |
| doi.org/10.1007/s002770050188, hdl.handle.net/1765/71493 | |
| Annals of Hematology | |
| Organisation | Department of Medical Microbiology and Infectious Diseases |
|
Mandigers, C., Mensink, E., Geurts van Kessel, A., van der Plas, D., Haanen, C., Hagemeÿer, A., & de Witte, T. (1996). A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone. Annals of Hematology, 72(6), 371–373. doi:10.1007/s002770050188 |
|
